Brighton Jones LLC Cytom X Therapeutics, Inc. Transaction History
Brighton Jones LLC
- $3.32 Billion
- Q4 2024
A detailed history of Brighton Jones LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Brighton Jones LLC holds 10,000 shares of CTMX stock, worth $5,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$5,900% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CTMX
# of Institutions
71Shares Held
46.1MCall Options Held
3.7KPut Options Held
4.7K-
Tang Capital Management LLC San Diego, CA7.31MShares$4.31 Million0.57% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$3.08 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.16MShares$3.05 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX3.91MShares$2.3 Million1.19% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.22MShares$1.9 Million0.0% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $38.9M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...